{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:46:38Z","timestamp":1759625198642,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaccas.2025.105229","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:38:27Z","timestamp":1758789507000},"page":"105229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["PET MPI With F-18 FlurpiridazVersus Rb-82"],"prefix":"10.1016","volume":"30","author":[{"given":"Maria","family":"Alwan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0767-2235","authenticated-orcid":false,"given":"Ahmad","family":"El Yaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Al Rifai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouaz H.","family":"Al-Mallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaccas.2025.105229_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2023.08.016","article-title":"Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease","volume":"82","author":"Maddahi","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jaccas.2025.105229_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101896","article-title":"The role of splenic switch-off in assessing vasodilator response: when less is more","volume":"38","author":"Al-Mallah","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jaccas.2025.105229_bib3","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s12350-018-1269-9","article-title":"Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging","volume":"26","author":"Bami","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jaccas.2025.105229_bib4","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s12350-022-03158-3","article-title":"Splenic switch-off in regadenoson (82)Rb-PET myocardial perfusion imaging: assessment of clinical utility","volume":"30","author":"Saad","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jaccas.2025.105229_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101868","article-title":"Splenic switch-off in [(15)O]H(2)O-positron emission tomography myocardial perfusion imaging using parametric blood flow images","volume":"38","author":"Brorson","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.jaccas.2025.105229_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.semnuclmed.2014.06.011","article-title":"Cardiac PET perfusion tracers: current status and future directions","volume":"44","author":"Maddahi","year":"2014","journal-title":"Semin Nucl Med"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925020091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925020091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T23:46:12Z","timestamp":1759621572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925020091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":6,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666084925020091"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.105229","relation":{},"ISSN":["2666-0849"],"issn-type":[{"type":"print","value":"2666-0849"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PET MPI With F-18 FlurpiridazVersus Rb-82","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.105229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"105229"}}